ST
XPH icon

Spot Trading’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Spot Trading’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,527
Closed -$334K – 4072
2015
Q4 		$334K Sell
6,527
-3,262
-33% -$166K ﹤0.01% 2172
2015
Q3 		$459K Buy
+9,789
New +$590K ﹤0.01% 2113

Other funds holding XPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Spot Trading's XPH Position: Q1 2016 in Review

Spot Trading sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2016, closing a stake of 6,527 shares — an estimated $334K sold.

Spot Trading first reported a position in XPH in Q3 2015 and held it in 2 quarters. The position peaked at $459K in Q3 2015. 71 funds tracked by Wall St. Rank hold XPH as of Q1 2016.

  • Spot Trading reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 6,527 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2016, an estimated $334K.
  • Spot Trading first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2015 and held it in 2 quarters.
  • Spot Trading's State Street SPDR S&P Pharmaceuticals ETF position peaked at $459K in Q3 2015.
  • 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.